Tenon Medical, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $3.6M
- Price
- $3.50
- % Change (Daily % change from the live per-ticker quote feed.)
- -5.79%
- Volume
- 356.2K
About
Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along its longitudinal axis. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
Quick stats
Shares outstanding1.0M
Computed float956.3K
Float / shares92.6%
Key info
SectorHealthcare
IndustryMedical - Devices
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001560293
Websitehttps://www.tenonmed.com
AI Summary
AI-generated1/26
minorbullishproduct launch
Tenon(R) Medical Announces Full Commercial Launch of the SImmetry(R)+ SI Joint Fusion 3D Printed Lateral Screw Following Successful Alpha Launch
Tenon Medical announced the full commercial launch of its titanium 3D-printed lateral screw for the SImmetry+ SI Joint Fusion System following a successful Alpha launch.
The limited Alpha launch generated approximately $1.2 million in preliminary, unaudited incremental revenue from late Q4 2025 through Q3 2026, with positive physician feedback and two additional implant sizes added to the portfolio.
Management views SImmetry+ — acquired from SiVantage and SIMPL Medical in August 2025 — as a meaningful growth driver, with several additional product launches expected in coming quarters.
Red flags
- Alpha launch revenue figure is preliminary and unaudited
- small-cap commercial launch; revenue contribution still immaterial relative to a scaled business